Prospective analysis of the factors influencing the antibody response to hepatitis b vaccine in hemodialysis patients

1997 ◽  
Vol 29 (2) ◽  
pp. 239-245 ◽  
Author(s):  
Ramón Peces ◽  
Miguel de la Torre ◽  
Roberto Alcázar ◽  
JoséM. Urra
Keyword(s):  
Hepatitis B ◽  
Antibody Response ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Prospective Analysis ◽  
Factors Influencing

Hepatitis B Vaccine in the Gambian Expanded Programme on Immunization: Factors Influencing Antibody Response

1991 ◽  
Vol 20 (3) ◽  
pp. 764-769 ◽  
Author(s):  
H M INSKIP ◽  
A J HALL ◽  
J CHOTARD ◽  
F LOIK ◽  
H WHITTLE
Keyword(s):  
Hepatitis B ◽  
Antibody Response ◽  
Hepatitis B Vaccine ◽  
Factors Influencing

Recombinant Hepatitis B Vaccine Use in Chronic Hemodialysis Patients

Nephron ◽  
1996 ◽  
Vol 72 (4) ◽  
pp. 536-543 ◽  
Author(s):  
F. Fabrizi ◽  
S. Di Filippo ◽  
D. Marcelli ◽  
I. Guarnori ◽  
L. Raffaele ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis

Lower Long-term Efficiency of Intradermal Hepatitis b Vaccine Compared to the Intramuscular Route in Hemodialysis Patients

1999 ◽  
Vol 22 (11) ◽  
pp. 739-743 ◽  
Author(s):  
D.A. Vlassopoulos ◽  
D.K. Arvanitis ◽  
D.S. Lilis ◽  
K.I. Louizou ◽  
V.E. Hadjiconstantinou
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Intramuscular Route

scholarly journals Immunization aganist hepatitis B in children from endemic zone: evaluation of the antibody response against the DNA recombinant vaccine (Engerix B-20 mcg)

1993 ◽  
Vol 35 (1) ◽  
pp. 89-92 ◽  
Author(s):  
C.R.B. Ferreira ◽  
C.F.T. Yoshida ◽  
L.A.C. Mercadante ◽  
D.F. Gomes ◽  
J.M. Oliveira ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Antibody Response ◽  
Recombinant Dna ◽  
Hepatitis B Surface Antigen ◽  
Vaccine Dose ◽  
Vaccination Schedule ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis ◽  
The Third ◽  
Rural Zone

A previous seroepidemiological study in the rural zone of Vargem Alta (ES) SouthEast of Brazil, showed a prevalence of up to 9% of hepatitis B surface antigen (HBsAg) in some areas. One hundred susceptible children aging 1 to 5 years old were selected and immunized with a recombinant DNA hepatitis B vaccine (Smith-Kline 20 mcg) using the 0-1-6 months vaccination schedule. Blood samples were collected at the time of the first vaccine dose (month 0) in order to confirm susceptible individuals and 1,3,6 and 8 months after the first dose , to evaluate the antibody response. Our results showed that two and five months after the second dose, 79% and 88% of children seroconverted respectively, reaching 97% after the third dose. The levels of anti-HBs were calculated in milli International Units/ml (mIU/ml) and demonstrated the markedly increase of protective levels of antibodies after the third dose. These data showed a good immunogenicity of the DNA recombinant hepatitis B vaccine when administered in children of endemic areas.

Comparison of Intramuscular and Intradermal Applications of Hepatitis B Vaccine in Hemodialysis Patients

Renal Failure ◽  
2006 ◽  
Vol 28 (7) ◽  
pp. 561-565 ◽  
Author(s):  
M. Kasım Karahocagil ◽  
Turan Buzgan ◽  
Hasan Irmak ◽  
Hasan Karsen ◽  
Hayrettin Akdeniz ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine
Sign in / Sign up

Export Citation Format

Share Document